About Us
Clinical trials services
Focus on conducting Phase II, III & IV clinical trials
Provide one-stop service with qualified Principal Investigator,
Experienced research staff & advanced facilities,
Good compliance with GCP & protocol
Patient centered service
High efficiency with fast start-up, high recruitment & retention rate and low screen failure rate
Facilities
Locked cabinets & 2-8°C refrigerators for drug storage,
Biological specimen storage area -20°C and -80°C Freezers
Biological Safety Cabinet for drug preparation
Refrigerated centrifuge for sample processing
ECG, Ultrasound, Echo, Holter Monitoring
Endoscopy, IV Infusions system
Imaging scans: X-ray, CT, MRI, PET
Key Investigators
Dr. George Lau
Viral Hepatitis, Liver Cancer & Clinical Drug Development
Dr. Patrick Lau
Clinical Oncology, Immuno-Oncology & Precision Cancer Therapeutics
Dr. Gregory Cheng
Haematology, Thrombosis & Blood Cancer Research
Our Achievements
Completed > 30 clinical trials
“Average study start-up period is less than 3 months”
-
Randomized 8 patients in 6 months! One of the fast global recruitment sites.
An advanced ALK positive NSCLC study
-
Randomized 4 patients, 0% screen failure rate.
A study of advanced HCC with no previous systemic anticancer therapy and a primary biliary cirrhosis study.
-
Randomized 41 patients in total, in which 30 is achieved in 6 months. One of the top global recruitment sites.
A study of unsesectable HCC.
